A Genetic Marker for Huntington's Chorea
BMJ 287:1567-1568, Harper,P.S., 1983
Huntington's Chorea:Neglected Opportunities for Preventive Medicine
Lancet 1:634-636, Martindale,B.,et al, 1983
Maternal Transmission in Huntington's Disease
Lancet 1:208-210, Myers,R.H.,et al, 1983
Positron Computed Tomography for Studies of Myocardial & Cerebral Function
Ann Int Med 98:339-359, Phelps,M.E.,et al, 1983
Treatment of Hyperkinetic Movement Disorders with Tetrabenazine:A Double-blind Crossover Study
Ann Neurol 11:41-47, Jankovic,J., 1982
False-Negative Results With Levodopa For Early Detection Of Huntington's Disease
NEJM 307:561-562, Myers,R.H.,et al, 1982
Attitudes Of Those At Risk For Huntington's Disease Toward Presymptomatic Provocative Testing
NEJM 307:1406, McCormack,M.K., 1982
Neurotransmitters & CNS Disease, Basal Ganglia Disease
Lancet 2:1141-1147, Marsden,C.D., 1982
Neuroleptics & Abnormal Movements
BMJ 285:463-464, Lader,M.H., 1982
Levodopa & Presymptomatic Detection of Huntington's Disease-Eight-Year Follow-Up
NEJM 302:1090, Klawans,H.L.,et al, 1980
Presymptomatic & Early Detection in Huntington's Disease
Ann Neurol 8:343-347, Klawans,H.L.,et al, 1980
Levels of y-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
Arch Neurol 37:352-355, Manyam,N.V.B.,et al, 1980
Huntington's Disease:Abnormality of Lymphocyte Capping
Ann Neurol 6:447-450, Noronha,A.B.C.,et al, 1979
Studies of the Fluorescence of Fibroblasts From Huntington's Disease:Evidence of a Membrane Abnormality
NEJM 300:678, Pettegrew,J.,et al, 1979
Isoniazid Therapy of Huntington Disease
Neurol 29:370-375, Perry,T.L.,et al, 1979
Huntington's Disease, CSF GABA Level in at-risk Individuals
Arch Neurol 35:728-730, Manyam,N.V.B.,et al, 1978
Huntington's Disease:Treatment with Muscimol, a GABA-Mimetic Drug
Ann Neurol 4:279-284, Shoulson,I.,et al, 1978
Huntington Disease Associated with Alzheimer Disease
Ann Neurol 3:545, McIntosh,G.C.,et al, 1978
The Visually Evoked Potential in Huntington disease
Neurol 28:95, Ellenberger,C.,et al, 1978
Juvenile Huntington Chorea:Clinical, Ultrastructural, & Biochemical Studies
Neurol 28:23, Goebel,H.H.,et al, 1978
Lecithin in Neurologic Disorders
NEJM 299:200, 1978 (Letter) ., Barbeau,A., 1978
Apomorphine Hydrochloride-Induced Improvement in Huntington's Chorea
Arch Neurol 35:27, Corsini,G.U.,et al, 1978
Bicaudate Index in Computerized Tomography of Huntington Disease & Cerebral atrophy
Neurol 28:1196-1200, Barr,A.N.,et al, 1978
Identification of GABA in Human CSF by Gas Liquid Chromatography & Mass Spectrometry
NEJM 296:692, Huizinga,J.D.,et al, 1977
Treatment of Huntington's Chorea with Isoniazid
NEJM 297:840, 1977. (Letter), Perry,T.L.,et al, 1977
Huntington's Chorea, Changes in Neurotransmitter Receptors in the Brain
NEJM 294:1305, Enna,S.J.,et al, 1976
Computerized Axial Tomography-Use in the Dx. of Dementia
JAMA 234:754, Menzer,L.,et al, 1975
Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975
Clinical Neuropathological Conference
(Ed) , Dis Ner Sys 34:124, 1973, Pick's Disease., Aronson,S.&Aronson,B., 1973
Huntington's Disease in Children
Neurol 23:561, Byers,R.,et al, 1973
Clinical Diagnosis of the Dyskinesias
Med Clin of North Am 56:1321, Duvoisin,R., 1972
Presymptomatic Detection of Huntington's Chorea
BMJ 540, 1972 Sept., , 1972
Huntington's Disease-Newspaper Article-Boston Globe
May 7, 1972, , 1972
Huntington's Chorea, Effect of Serotonin Depletion
Arch Neurol 26:282, Chase,T.,et al, 1972
Use of L-Dopa in the Detection of Presymptomatic Huntington's Chorea
NEJM 286:1332, Klawans,H.,et al, 1972
The EEG in Huntington's Chorea:A Clinical & Neuropathological Study
JNNP 35:97-102, Scott,D.F.,et al, 1972
Cholinergic & Dopaminergic Mechanisms in Huntington's Chorea
Life Sciences 10:405 1971., Aquilonius,S.,et al, 1971
Diseases of the Extrapyramidal System
Disease-a-month-Jan 1970., Klawans,H.,et al, 1970
Pneumoencephalographic Findings in Huntington's Chorea
Neurol 18:991, Gath,I.,et al, 1968
Huntington's Chorea
Bruyn, G. W. In Vinken & Bruyn, Handbk of Clin Neurol, North-Holland Publ Co, Amsterdam, 6:298, , 1968
Diseases of the Basal Ganglia-Their Relation to Disorders of Movement
Lancet 1099, 1960, Nov., Denny-Brown,D., 1960
Anti-NMDA Receptor Encephalitis Presenting with Cerebellitis in a Pediatric Patient
Neurol 102:e209259, Moehlman,M. & Kornbluh,A.B., 2024
Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis
Ann Neurol 96:21-33, Gilligan,M.,et al, 2024
Slowly rogressive Cerebellar Ataxia in a 55-Year-Old Female Patient
JAMA Neurol 80:107-108, Bernaola,M.T.,et al, 2023
Current and Emerging Issues in Wilsons Disease
NEJM 389:922-938, Roberts,E.A. & Schilsky, M.L., 2023
Clinicopathologic Conference,Limb-Shaking Transient Ischemia Attacks
NEJM 389:1416-1423, Case 31-2023, 2023
Movement Disorders in Patients with Genetic Developmental and Epileptic Encephalopathies
Neurol 101:e1884-e1892, van der Veen,S.,et al, 2023
Clinicopathologic Conference, Antiphospholipid Syndrome due to SLE with Hypocomplimentemia
NEJM 389: 2277-2285, Case 38-2023, 2023
The Phenotypic Continuum of ATP1A3-Related Disorders
Neurol 99:e1511-e1526, Vezyroglou,A., et al, 2022
A 77-Year-Old Man with Involuntary Movements, Sleep Changes, Falls, Bulbar Symptoms, and Cognitive Complaints
Neurol 99:26-30, Cao, T.Q.,et al, 2022